This presentation has four goals:
	1) to introduce the major families of psychiatric medications
	2) to explain current trends in the USA’s consumption of pharmaceuticals
	3) to describe the kinds of medical conditions which commonly affect patients                                       who receive mental health care from publicly funded sources (e.g., Medicaid)
	and
	4) to explain the serious health risks which are associated with psychiatric drug treatments.